Patient Guide: A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06655324
Status: 🟢 Enrolling Now
Condition:
Phase: PHASE1

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Glendale, California
  • • Miami, Florida
  • • Kansas City, Missouri
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001). - Join Clinical Trial NCTNCT06655324

How to Join This Clinical Trial - NCTNCT06655324

Learn how to participate in this PHASE1 trial studying an investigational therapy for your medical condition. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with specific medical conditions. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Medical condition under investigation
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06655324 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Glendale, California 91206 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Miami, Florida 33143 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64114 - United States

Status: RECRUITING

Clinical Research Site

Springfield, Missouri 65802 - United States

Status: RECRUITING

Clinical Research Site

Lincoln, Nebraska 68510 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68134 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Ohio 43215 - United States

Status: RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73112 - United States

Status: RECRUITING

Clinical Research Site

Knoxville, Tennessee 37909 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for :

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships